ask="4.200"
ask_size="5600"
average_daily_volume="452081"
bid="1.130"
bid_size="200"
book_value="3.738"
change="-0.165"
change_from_200_day_moving_average="1.909"
change_from_50_day_moving_average="-1.047"
change_from_52_week_high="-6.935"
change_From_52_week_low="0.015"
change_in_percent="-3.919%"
close="4.045"
dividend_pay_date="N/A"
dividend_per_share="0.000"
dividend_yield="0.000"
earnings_per_share="-3.367"
ebitda="-41.42M"
eps_estimate_current_year="5.020"
eps_estimate_next_quarter="-0.500"
eps_estimate_next_year="-2.030"
ex_dividend_date="N/A"
float_shares="13385000"
high="4.340"
high_52_weeks="10.980"
last_trade_date="1/18/2017"
last_trade_price="4.045"
last_trade_size="200"
last_trade_time="4:00pm"
low="4.030"
low_52_weeks="4.030"
market_capitalization="91.22M"
moving_average_200_day="2.136"
moving_average_50_day="5.092"
name="Cascadian Therapeutics
Inc."
notes="N/A"
one_year_target_price="390.000"
open="4.220"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="+89.376%"
percent_change_from_50_day_moving_average="-20.568%"
percent_change_from_52_week_high="-63.160%"
percent_change_from_52_week_low="+0.372%"
previous_close="4.210"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.126"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="22551000"
short_ratio="4.040"
stock_exchange="NMS"
symbol="CASC"
volume="154400"
weeks_range_52="4.030 - 10.980"
